RECORDED WEBINAR

BMI on Trial: Should It Still Define Obesity

     

OVERVIEW

Explore this recorded session from the American Diabetes Association’s 2026 Scientific Sessions debate on whether BMI should remain central to obesity diagnosis. Hear about BMI’s strengths and limitations, the Lancet Commission’s distinction between clinical and preclinical obesity, and implications for assessment, treatment, and access to care.

LEARNING OBJECTIVES

  • Identify the strengths and limitations of BMI when assessing adiposity and obesity-related health risk.
  • Distinguish clinical obesity from preclinical obesity using the diagnostic framework proposed by the Lancet Commission on Clinical Obesity. 
  • Select an appropriate approach to confirming excess adiposity and evaluating obesity-related organ or functional impairment.
  • Identify how different obesity definitions may affect risk stratification, treatment goals, resource allocation, and access to care.  

EXPIRATION DATE

December 31, 2027

FACULTY 

Leigh Perrault, MD, DABOM
Franceso Rubino, MD

 

This program is funded in part through an unrestricted educational grant from Novo Nordisk.

Note: You do not need to be an ADA professional member to access our free continuing education programs. Simply create a free account and start exploring 70+ free CE courses. Login to get started!

Android App Download IOS App Download Powered By